Table 1.
Structure | Constraint type | Volume | Dose | Priority |
---|---|---|---|---|
PTV and CTV | Upper | 0% | 101% | Generated |
Lower | 100% | 99.0% | Generated | |
Lungs | Upper | 20% | Generated | Generated |
Mean | – | Generated | Generated | |
Line | Generated | Generated | Generated | |
Breasts | Upper gEUD | 35.0 (#) | Generated | Generated |
Upper gEUD | 1.0 (#) | Generated | Generated | |
line | Generated | Generated | Generated | |
Heart | Upper gEUD | 35.0 (#) | Generated | Generated |
Upper gEUD | 1.0 (#) | Generated | Generated | |
line | Generated | Generated | Generated | |
Oesophagus | Upper gEUD | 35.0 (#) | Generated | Generated |
Upper gEUD | 1.0 (#) | Generated | Generated | |
line | Generated | Generated | Generated | |
Stomach | Upper gEUD | 35.0 (#) | Generated | Generated |
Upper gEUD | 1.0 (#) | Generated | Generated | |
line | Generated | Generated | Generated | |
Bowel bag | Upper gEUD | 35.0 (#) | Generated | Generated |
Upper gEUD | 1.0 (#) | Generated | Generated | |
line | Generated | Generated | Generated | |
Kidneys | Upper gEUD | 35.0 (#) | Generated | Generated |
Upper gEUD | 1.0 (#) | Generated | Generated | |
line | Generated | Generated | Generated | |
Spinal cord | Upper gEUD | 35.0 (#) | Generated | Generated |
Upper gEUD | 1.0 (#) | Generated | Generated | |
line | Generated | Generated | Generated | |
Liver | Upper gEUD | 35.0 (#) | Generated | Generated |
Upper gEUD | 1.0 (#) | Generated | Generated | |
Upper gEUD | Generated | Generated | Generated | |
Spleen | Upper gEUD | 35.0 (#) | Generated | Generated |
Upper gEUD | 1.0 (#) | Generated | Generated | |
line | Generated | Generated | Generated |
Heart, breasts, stomach, kidneys, liver and spleen were modelled and trained separately if ipsi- or if contra-lateral. For the lungs, only the contralateral volume was considered
CTV: clinical target volume; PTV: planning target volume; gEUD: generalized equivalent uniform dose; (#) the α parameter of gEUD; α = 1 correspond to the mean dose while α = 35 acts on the high dose region, in proximity of the near-to-maximum dose